Reduction of diabetes incidence in NOD mice by neonatal glucose treatment

T. Bock,T. W. Kjaer,M. Jorgensen,K. Josefsen,Jørgen Rygaard,Karsten Buschard
DOI: https://doi.org/10.1111/j.1699-0463.1991.tb01289.x
1991-07-01
Abstract:The aim of this study was to investigate whether neonatal glucose treatment influences the incidence of diabetes in NOD mice. Thirty‐nine NOD mice (19 males, 20 females) were treated with 8 g glucose/ kg BW/day administered by subcutaneous injections twice a day for the first six days of life. Thirty‐six untreated NOD mice (20 males, 16 females) served as a control group. In the glucose‐treated group, 33% became diabetic compared with 58% in the control group (X2= 5.3, p = 0.021). Among the glucose‐treated males, 16% became diabetic compared with 50% of the untreated males (X2= 5.5, p = 0.019), whereas 50% of the glucose‐treated females became diabetic compared with 69% of the untreated females (X2= 1.1, NS). We conclude that neonatal glucose treatment can reduce the diabetes incidence in NOD mice. These results could have implications for the prevention of type 1 diabetes mellitus in humans.
What problem does this paper attempt to address?